WEDNESDAY, JANUARY 26, 2022
North America: 2pm EST / 11am PST | Europe: 1pm GMT
In some domains, good enough isn’t good enough; exceptional performance is required every time.
Increasingly, data science is one of these fields. It’s a discipline in which small differences in performance can have massive impact. Slight modeling improvements can drive millions of dollars of incremental revenue. Small mistakes can result in colossal losses.
Doctors know this situation well, as every decision they make can have life-altering consequences.
Join us for a special virtual event on January 26th to learn how to unleash exceptional performance through continuous improvement in 2022.
Renowned surgeon, author, and performance improvement expert, Atul Gawande, will share his unique insights from years of driving continuous improvement inside hospitals.
He will share how coaching, checklists, best practices, and other techniques can drive performance improvement.
Najat Khan will also join the virtual stage to share her perspective on continuous improvement at the intersection of medical research and data science.
In her transformative role leading data science at Johnson & Johnson, Dr. Khan will bring frontline insights at a time when the work of teams like hers is benefitting billions of people around the world.
The lessons of Dr. Gawande and Dr. Khan will come together as Nick Elprin, CEO of Domino Data Lab, connects them to data science and the concept of model velocity. Maximizing model velocity means achieving near-continuous performance improvement in a model-driven business.
To support companies looking to accelerate model velocity, Elprin will also reveal Domino 5.0, a major step forward in our mission to help businesses unleash the power of data science.
Atul Gawande has become one of the most influential healthcare voices in the world. He was recently nominated by President Biden to lead global health development at the U.S. Agency for International Development (USAID). His current day job is as a surgeon at Boston-based Brigham & Women’s Hospital. He’s also executive director of a Harvard center dedicated to improving critical care. Gawande is an award-winning author of four New York Times bestsellers: Complications, Better, The Checklist Manifesto, and Being Mortal.
Najat Khan is responsible for identifying and executing high-impact initiatives across Discovery and Development, including by curating external partnerships that enrich data availability and enable rapid deployment and scale. These data science efforts span Janssen’s portfolio. Najat also serves as Global Head of Janssen R&D Strategy & Operations and co-leads the cross-sector Johnson & Johnson Data Science Council. Najat received her B.A. in Chemistry from Colgate University and her Ph.D. in Organic Chemistry from the University of Pennsylvania.
Nick Elprin is the CEO and co-founder of Domino Data Lab, provider of the Enterprise MLOps platform that powers model-driven companies such as J&J, Ford, Dell and Verizon. Before starting Domino, Nick built tools for quantitative researchers at Bridgewater, one of the world’s largest hedge funds. He has over a decade of experience working with data scientists at advanced enterprises. He holds a BA and MS in computer science from Harvard.